Parmax Pharma Ltd - PARMAX PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE240T01014

Trade

Parmax Pharma Ltd Corporate Actions

23 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Feb , 2023

12:00 AM

Results

View Details

05 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Nov , 2022

12:00 AM

Results

View Details

08 Sep , 2022

12:00 AM

AGM

Announcement date: 08 Sep , 2022

View Details

04 Aug , 2022

12:00 AM

Results

View Details

04 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

08 Sep , 2022

12:00 AM

BookCloser

View Details

Parmax Pharma Ltd News and Update

Centre to Sell 3% Stake in Coal India Ltd, Aims to Raise ₹4,158 Crore

14 hours ago |
5:43 PM

The floor price for the two-day OFS is set at ₹225 per share.

Lupin bags USFDA approval for Obeticholic Acid Tablets

IIFL News Service |
16 hours ago |
5:43 PM

Torrent Pharma surges ~5% on posting robust performance in Q4FY23

IIFL News Service |
1 day ago |
5:42 PM

Markets in a bloodbath; IT, Pharma hold ground

IIFL News Service |
1 day ago |
5:41 PM

Parmax Pharma Ltd FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Parmax Pharma Ltd PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	987.50	51.76	2,36,934.33	-1,020.82	1.16	5,800.85	98.98
Divis Laboratories Ltd	3,524.75	51.75	93,571.04	318.79	0.85	1,908.17	478.60
Cipla Ltd	964.25	29.93	77,830.13	355.49	0.88	3,485.68	305.25
Dr Reddys Laboratories Ltd	4,551.20	29.01	75,790.26	672.40	0.88	4,537.80	1,229.47
Torrent Pharmaceuticals Ltd	1,775.15	57.12	60,079.14	219.00	1.24	1,882.00	190.76

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

Parmax Pharma Ltd - PARMAX PHARMA Share Price

Parmax Pharma Ltd KEY RATIOS

Parmax Pharma Ltd Corporate Actions

Parmax Pharma Ltd SHAREHOLDING SNAPSHOT
02 June , 2023 | 04:45 AM

Knowledge Center

Parmax Pharma Ltd News and Update

Centre to Sell 3% Stake in Coal India Ltd, Aims to Raise ₹4,158 Crore

Lupin bags USFDA approval for Obeticholic Acid Tablets

Torrent Pharma surges ~5% on posting robust performance in Q4FY23

Markets in a bloodbath; IT, Pharma hold ground

Parmax Pharma Ltd FINANCIALS

Select Period:

Parmax Pharma Ltd QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

Parmax Pharma Ltd PEER COMPARISON

MORE ABOUT Parmax Pharma Ltd

Summary

IIFL Customer Care Number

1860-267-3000 /7039-050-000

IIFL Securities Support Whatsapp Number

+91-9892691696

Download The App Now

IIFL Customer Care Number

1860-267-3000 /7039-050-000

IIFL Securities Support Whatsapp Number

+91-9892691696

Download The App Now

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Parmax Pharma Ltd - PARMAX PHARMA Share Price

Parmax Pharma Ltd KEY RATIOS

Parmax Pharma Ltd Corporate Actions

Parmax Pharma Ltd SHAREHOLDING SNAPSHOT 02 June , 2023 | 04:45 AM

Knowledge Center

Parmax Pharma Ltd News and Update

Parmax Pharma Ltd FINANCIALS

Select Period:

Parmax Pharma Ltd QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

Parmax Pharma Ltd PEER COMPARISON

MORE ABOUT Parmax Pharma Ltd

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

Parmax Pharma Ltd SHAREHOLDING SNAPSHOT
02 June , 2023 | 04:45 AM